Comprehensive Medical Screening: Clinicians should evaluate for: Thyroid nodules or goiter : Baseline neck examination and review of recent thyroid ultrasound if clinically indicated Personal or family history of thyroid cancer : Particularly medullary thyroid carcinoma Comorbid conditions : Type 2 diabetes, cardiovascular disease, pancreatitis history Gastrointestinal disorders : Severe gastroparesis (potential contraindication) Renal function : Use caution in patients at risk for volume depletion/renal impairment Psychiatric conditions : Depression, eating disorders Pregnancy status : These medications are not recommended during pregnancy and should be discontinued when pregnancy is recognized Laboratory Assessment: Baseline testing should include: TSH and free T4 Comprehensive metabolic panel (renal and hepatic function) Lipid panel Hemoglobin A1c (if diabetic or prediabetic) Routine calcitonin screening or thyroid ultrasound is not recommended solely for GLP-1 therapy initiation

A statistically significant increase in thyroid C-cell adenomas was observed in males (0.5 mg/kg) and females (0.15 mg/kg), and a statistically significant increase in thyroid C-cell adenomas and carcinomas combined was observed in males and females at all doses examined
Other ways to save on Rybelsus include SingleCare coupons, manufacturer savings programs, trying alternatives, and comparing prices
Efficacy signal: Trial data shows tirzepatide achieves 20.9% average weight loss (SURMOUNT-1) versus semaglutide's 14.9% (STEP 1), but individual outcomes vary and no obesity-specific switching trial exists yet
Carbohydrate drink mix with electrolytes and flavorings